About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT06700317

Intraoperative Hyperspectral Imaging for Laparoscopic Surgery

The study aims to evaluate the use of the HyperSnap Surgical System (HSS1) during laparoscopic surgeries, specifically in bowel resections and cholecystectomies.

Lead sponsor: King's College London•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Jonathan Shapey, PhD FHEA FRCS

CONTACT

+44 20 7836 5454 jonathan.shapey@kcl.ac.uk

Sponsors

Lead Sponsor

King's College London

The study will observe patients undergoing bowel resection and cholecystectomy surgeries to determine if HyperSnap Surgical System (HSS1), as a primary visualisation tool, functions safely and capably as a laparoscopic imager. In addition, we will see if it subjectively improves the identification of critical anatomical structures. In addition, the study will secondarily assess how StO2 information may be included in the surgical workflow and how surgeons may react to this additional information.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•A) Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy)
•Adult patients aged 18 years and over
•Common bile duct diameter \< 8mm as assessed using ultrasound
•Patients able to provide written informed consent
•B) Colorectal cancer requiring elective bowel resection via a laparoscopic approach.
•Adult patients aged 18 years and over
•Patients who are scheduled for elective laparoscopic colon cancer resection
•Patients able to provide written informed consent

Exclusion Criteria

•A) Cholelithiasis or cholecystitis with indications for laparoscopic surgery (cholecystectomy)
•Patients under 18 years of age
•Patients with a history of previous abdominal surgery and multiply scarred abdomen
•Common bile duct diameter ≥ 8mm as assessed using ultrasound
•Patients unable to provide written informed consent
•Patients who are pregnant
•B) Colorectal cancer requiring elective bowel resection via a laparoscopic approach.
•Patients under 18 years of age
•Patients with a history of previous abdominal surgery and multiply scarred abdomen
•Patients unable to provide written informed consent
•Patients undergoing emergency surgery
•Patients who are pregnant

Related studies

The Impact of Image-Assisted Colonoscope on Patient Experience, Physician Workload, and Examination Quality

NCT07541924 · Colorectal Cancer Screening, Colonic Polyps/Colonoscopy/Colorectal Neoplasms, and more

RECRUITINGPhase 3

EUS-GBD vs Antibiotics for Patients at High Risk for Cholecystectomy

NCT05893511 · Acute Cholecystitis

RECRUITINGPhase 3

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

NCT06662786 · Colorectal Neoplasms

RECRUITINGPhase 1

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms

CRP Point-of-care Testing Trajectory, a Predictive Factor for Anastomotic Leak in Elective Colorectal Surgery

NCT07464600 · Colorectal Surgery, Enhanced Recovery, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 21, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment40

Start dateFeb 2025

Last updatedNov 21, 2024

Condition

Colorectal Neoplasms Colorectal Surgery Cholecystitis Cholecystectomy, Laparoscopic

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 21, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions